A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion

Journal of Clinical Investigation

Volumn 121, Issue 9, 2011, Pages 3589-3597

  Ravassard, Philippe ^a,b,c   Hazhouz, Yasmine ^b,d   Pechberty, Séverine ^d,e   Bricout Neveu, Emilie ^b,d   Armanet, Mathieu ^f,g   Czernichow, Paul ^d   Scharfmann, Raphael ^c,e  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

^c INSERM   (France)

^d Endocells   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MAST CELL FUNCTION ASSOCIATED ANTIGEN; NEUROGENIC DIFFERENTIATION FACTOR; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CELL TRANSPLANTATION; FETUS; GENETIC ENGINEERING; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULINOMA; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; CELL LINE; FETUS; GENE EXPRESSION PROFILING; GENETIC ENGINEERING; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INSULINOMA; MALE; MICE; MICE, SCID; PANCREAS;

EID: 80052343967     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI58447     Document Type: Article

References (46)

1. Beattie G.M., et al. Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes. 1999;48(5):1013-1019. (Pubitemid 29226347)
2. Russ H.A., Bar Y., Ravassard P., Efrat S. In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes. 2008;57(6):1575-1583.
3. Kroon E., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucoseresponsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443-452. (Pubitemid 351501814)
4. Asfari M., Janjic D., Meda P., Li G., Halban P., Wolheim K. Establishement of 2-mercaptoethanoldependent differentiated insulin secreting cell lines. Endocrinology. 1992;130(1):167-178.
5. Gazdar A., et al. Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci U S A. 1980;77(6):3519-3523. (Pubitemid 10012266)
6. Santerre R., et al. Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci U S A. 1981;78(7):4339-4342.
7. Efrat S., et al. β cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci U S A. 1988;85(23):9037-9041.
8. Miyazaki J., et al. Establishment of a pancreatic beta cell line that retains glucose- inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology. 1990; 127(1):126-132. (Pubitemid 20228111)
9. Hohmeier H.E., Newgard CB. Cell lines derived from pancreatic islets. Mol Cell Endocrinol. 2004; 228(1-2):121-128.
10. de la Tour D, et al. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol. 2001;15(3):476-483.
11. Demeterco C., Itkin-Ansari P., Tyrberg B., Ford L.P., Jarvis R.A., Levine F. c-Myc controls proliferation versus differentiation in human pancreatic endocrine cells. J Clin Endocrinol Metab. 2002;87(7):3475-3485. (Pubitemid 34816406)
12. Gueli N., Toto G., Palmieri G., Carmenini G., Delfino A., Ferrini U. In vitro growth of a cell line originated from a human insulinoma. J Exp Clin Cancer Res. 1987;4:281-285. (Pubitemid 18053912)
13. Levine F., et al. Development of a cell line from human fetal pancreas. Transplant Proc. 1995; 27(6):3410. (Pubitemid 26016246)
14. Narushima M., et al. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol. 2005;23(10):1274-1282. (Pubitemid 41486855)
15. Hohmeier H.E., Newgard C.B. Islets for all? Nat Biotechnol. 2005;23(10):1231-1232.
16. Castaing M., Duvillie B., Quemeneur E., Basmaciogullari A., Scharfmann R. Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev Dyn. 2005;234(2):339-345. (Pubitemid 41369143)
17. Castaing M., Peault B., Basmaciogullari A., Casal I., Czernichow P., Scharfmann R. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia. 2001;44(11):2066-2076. (Pubitemid 33124053)
18. Scharfmann R., Xiao X., Heimberg H., Mallet J., Ravassard P. Beta cells within single human islets originate from multiple progenitors. PLoS One. 2008;3(10):e3559.
19. Ling Z., Pipeleers D. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest. 1996;98(12):2805-2812. (Pubitemid 26427409)
20. Melloul D., Marshak S., Cerasi E. Regulation of insulin gene transcription. Diabetologia. 2002;45(3):309-326. (Pubitemid 34267353)
21. Schuit F.C. Is GLUT2 required for glucose sensing? Diabetologia. 1997;40(1):104-111. (Pubitemid 27035719)
22. Thorens B., Sarkar H., Kaback H., Lodish H. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell. 1988;55(2):281-290.
23. DeVos A., et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest. 1995;96(5):2489-2495.
24. Ferrer J., Benito C., Gomis R. Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes. 1995;44(12):1369-1374.
25. Eizirik D., Pipeleers D., Ling Z., Welsh N., Hellerstrom C., Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci U S A. 1994;91(20):9253-9256. (Pubitemid 24297892)
26. Eizirik D.L., Welsh N., Hellerstrom C. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets. J Clin Endocrinol Metab. 1993;76(2):399-403. (Pubitemid 23073063)
27. Fiaschi-Taesch N.M., et al. Induction of human betacell proliferation and engraftment using a single G1/S regulatory molecule, cdk6. Diabetes. 2010; 59(8):1926-1936.
28. Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 1990;10(8):4239-4242.
29. Parnaud G., et al. Proliferation of sorted human and rat beta cells. Diabetologia. 2008;51(1):91-100. (Pubitemid 50002201)
30. Friedlander S.Y.G., et al. Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras. Cancer Cell. 2009;16(5):379-389.
31. Itkin-Ansari P., et al. PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line. Mol Endocrinol. 2000;14(6):814-822. (Pubitemid 32260495)
32. Wang S., et al. Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant. 1997;6(1):59-67. (Pubitemid 27088032)
33. Polak M., Bouchareb-Banaei L., Scharfmann R., Czernichow P. Early pattern of differentiation in the human pancreas. Diabetes. 2000;49(2):225-232. (Pubitemid 30071001)
34. Ravassard P., et al. A new strategy to generate functional insulin-producing cell lines by somatic gene transfer into pancreatic progenitors. PLoS One. 2009; 4(3):e4731.
35. Haataja L., Gurlo T., Huang C.J., Butler P.C. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev. 2008;29(3):303-316. (Pubitemid 351679701)
36. Westermark G.T., Westermark P., Nordin A., Tornelius E., Andersson A. Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci. 2003; 108(3):193-203. (Pubitemid 39330064)
37. Westermark G.T., Westermark P., Berne C., Korsgren O. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med. 2008; 359(9):977-979.
38. Brandhorst H., Brandhorst D., Brendel M.D., Hering B.J., Bretzel R.G. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant. 1998;7(5):489-495. (Pubitemid 29046553)
39. Lukowiak B., et al. Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem. 2001;49(4):519-528.
40. Huypens P., Ling Z., Pipeleers D., Schuit F. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia. 2000;43(8):1012-1019. (Pubitemid 30655721)
41. Castaing M., Guerci A., Mallet J., Czernichow P., Ravassard P., Scharfmann R. Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells. Diabetologia. 2005;48(4):709-719. (Pubitemid 40591227)
42. Zufferey R., Nagy D., Mandel R.J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 1997; 15(9):871-875.
43. Ricordi C., Lacy P.E., Finke E.H., Olack B.J., Scharp D.W. Automated method for isolation of human pancreatic islets. Diabetes. 1988;37(4):413-420. (Pubitemid 18096377)
44. Attali M., et al. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes. 2007; 56(5):1248-1258. (Pubitemid 46715605)
45. Duvillie B., Attali M., Bounacer A., Ravassard P., Basmaciogullari A., Scharfmann R. The mesenchyme controls the timing of pancreatic {beta}-cell differentiation. Diabetes. 2006;55(3):582-589. (Pubitemid 43343213)
46. Haumaitre C., Lenoir O., Scharfmann R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol Cell Biol. 2008;28(20):6373-6383.